CD4 and esophageal squamous cell carcinoma: Since 2003, how the interplay between CD4+ and CD8+ T cells strongly correlates with esophageal SCC patients' prognosis has been shown,48 but the crucial question now is whether the immune infiltrate could predict the outcome after the neoadjuvant therapy.